Abstract
Background:Psoriatic Arthritis (PsA) is a complex immune-mediated disease. TNF inhibitors (TNFi) are the first-line biologic drugs to treat PsA, targeting soluble TNF-α (sTNF) and membrane-bound TNF-α (mTNF). TNFi are effective...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have